Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation

Interchangeability, a Food and Drug Administration (FDA) designation allowing pharmacists to substitute a biosimilar for its branded originator at the point of sale, is intended to increase biosimilar adoption. However, little is known about the relationship between interchangeability and biosimilar...

Celý popis

Podrobná bibliografie

Vydáno v:	Health affairs (Millwood, Va.) Ročník 44; číslo 11; s. 1417
Hlavní autoři:	Kakani, Pragya, Katcher, Bradley A, Maini, Luca
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.11.2025
Témata:	Biosimilar Pharmaceuticals - economics Biosimilar Pharmaceuticals - therapeutic use Health Benefit Plans, Employee - statistics & numerical data Humans Insurance Coverage - statistics & numerical data Interrupted Time Series Analysis Medicaid - statistics & numerical data United States United States Food and Drug Administration United States
ISSN:	2694-233X, 2694-233X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!